Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$232.35 -5.93 (-2.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Research & Development (2010 - 2026)

Updated

Jazz Pharmaceuticals (JAZZ) recorded Research & Development of $207.5 million in Q2 2026, up 9.3% from $189.9 million a year earlier and up 5.9% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Research & Development (2010 - 2026) Analysis & Trends

On a TTM basis, Jazz Pharmaceuticals' Research & Development came in at $815.61 million as of Jun 30, 2026, up 0.6% year-over-year; for FY2025, it was $782.74 million, down 11.5% from FY2024.

  • Annual Research & Development has a five-year compound annual growth rate of 18.5% (FY2020 to FY2025).
  • Across earlier years, Research & Development came in at $884 million in FY2024 (+4.0%), $849.66 million in FY2023 (+43.9%), $590.45 million in FY2022 (+16.7%) and $505.75 million in FY2021 (+50.8%).
  • Quarterly Research & Development has ranged from $129.98 million in Q1 2022 to $240.5 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Research & Development rose in three of the last eight quarters, with an average decline of 3.8%.
  • Peak year-over-year performance for Research & Development in the last five years was growth of 79.3% in Q3 2021, against a decline of 18.9% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $196 million (Q1 2026), $213.91 million (Q4 2025) and $198.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Jazz Pharmaceuticals 15.47 Bn 9.29 Bn 1.09 Bn 207.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 207.50 Mn
Mar 31, 2026 196.00 Mn
Dec 31, 2025 213.91 Mn
Sep 30, 2025 198.20 Mn
Jun 30, 2025 189.90 Mn
Mar 31, 2025 180.70 Mn
Dec 31, 2024 240.50 Mn
Sep 30, 2024 199.92 Mn
Jun 30, 2024 220.73 Mn
Mar 31, 2024 222.85 Mn
Dec 31, 2023 216.61 Mn
Sep 30, 2023 234.40 Mn
Jun 30, 2023 209.24 Mn
Mar 31, 2023 189.41 Mn
Dec 31, 2022 172.56 Mn
Sep 30, 2022 148.87 Mn
Jun 30, 2022 139.05 Mn
Mar 31, 2022 129.98 Mn
Dec 31, 2021 155.44 Mn
Sep 30, 2021 141.04 Mn
API Access

Jazz Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=JAZZ&period=max&api_key=YOUR_API_KEY